In this regard, it is logical to assume that the restoration of NAD+ can act as a promising approach to the treatment of AD by influencing the pathology of tau protein and inflammation, as well as DNA repair (Hou et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.